Cite

HARVARD Citation

    Langley, B. et al. (n.d.). Biomarkers of systemic inflammation predict survival in stage III non-small cell lung cancer treated with chemoradiotherapy. Lung cancer. pp. S53-S54. [Online]. 
  
Back to record